A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma

被引:13
|
作者
Lin, Zhuo [1 ]
Cai, Yi-Jing [1 ]
Chen, Rui-Cong [1 ]
Chen, Bi-Cheng [2 ]
Zhao, Liang [2 ]
Xu, Shi-Hao [2 ]
Wang, Xiao-Dong [1 ]
Song, Mei [1 ]
Wu, Jian-Min [3 ]
Wang, Yu-Qun [1 ]
Zhou, Meng-Tao [4 ]
Shi, Ke-Qing [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; MicroRNA; Vascular invasion; The Cancer Genome Atlas; Time-dependent receiver operating characteristic; PENALIZED LOGISTIC-REGRESSION; MICROVASCULAR INVASION; RNA; VALIDATION; SIGNATURE; MIGRATION; NETWORK; DISEASE; SYSTEM;
D O I
10.1016/j.cca.2017.03.026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The presence of vascular invasion (VI) in pathology specimens is a well-known unfavorable prognostic factor of hepatocellular carcinoma (HCC) recurrence and overall survival (OS). We investigated the vascular invasion related microRNA (miRNA) expression profiles and potential of prognostic value in HCC. Methods: miRNA and mRNA expression data for HCC were accessed from The Cancer Genome Atlas (TCGA). LASSO logistic regression models were used to develop a miRNA-based classifier for predicting VI. The predictive capability was accessed by area under receiver operating characteristics (AUG). Concordance index (C-index) and time-dependent receiver operating characteristic (td-ROC) were used to determine its prognostic value. We validated the predictive and prognostic accuracy of this classifier in an external independent cohort of 127 patients. Functionally relevant targets of miRNAs were determined using miRNA target prediction, experimental validation and correlation of miRNA and mRNA expression data. Results: A 16-miRNA-based classifier was developed which identified VI accurately, with AUC of 0.731 and 0.727 in TCGA set and validation cohort, respectively. C-index and td-ROC showed that the classifier was able to stratify patients into risk groups strongly associated with OS. When stratified by tumor characteristics, the classifier was still a clinically and statistically significant prognostic model. The predictive and prognostic accuracy of the classifier was confirmed in validation cohort. Vascular invasion related miRNA/target pairs were identified by integrating expression patterns of predicted targets, which were validated in cell lines. Conclusions: A multi-miRNA-based classifier developed based on the presence of VI, which could effectively predict OS in HCC.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 50 条
  • [31] Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma
    Lu, Mingqin
    Huang, Xiaoying
    Chen, Yongping
    Fu, Yangyang
    Xu, Chaona
    Xiang, Wei
    Li, Cheng
    Zhang, Shengguo
    Yu, Chang
    IUBMB LIFE, 2018, 70 (04) : 328 - 335
  • [32] Nomogram based on CMTM6 expression and clinical characteristics to predict postoperative overall survival in patients with hepatocellular carcinoma
    Dai, Mengjie
    Lan, Tao
    Chen, Hui
    Li, Xin
    Zhao, Zilong
    Jiang, Yingxue
    Yang, Long
    Wang, Songxiang
    HISTOLOGY AND HISTOPATHOLOGY, 2024, 39 (03) : 381 - 390
  • [33] Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma
    Zhong, Yue
    Yang, Yong
    He, Lei
    Zhou, Yang
    Cheng, Niangmei
    Chen, Geng
    Zhao, Bixing
    Wang, Yingchao
    Wang, Gaoxiong
    Liu, Xiaolong
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 301 - 312
  • [34] Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma
    Endo, Yutaka
    Lima, Henrique A.
    Alaimo, Laura
    Moazzam, Zorays
    Brown, Zachary
    Shaikh, Chanza F.
    Ratti, Francesca
    Marques, Hugo P.
    Soubrane, Olivier
    Lam, Vincent
    Poultsides, George A.
    Popescu, Irinel
    Alexandrescu, Sorin
    Martel, Guillaume
    Workneh, Aklile
    Guglielmi, Alfredo
    Hugh, Tom
    Aldrighetti, Luca
    Shen, Feng
    Endo, Itaru
    Pawlik, Timothy M.
    HPB, 2023, 25 (03) : 353 - 362
  • [35] Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma
    Takuma, Yoshitaka
    Shota, Iwadou
    Miyatake, Hirokazu
    Uematsu, Shuji
    Okamoto, Ryouichi
    Araki, Yasuyuki
    Takabatake, Hiroyuki
    Morimoto, Youichi
    Yamamoto, Hiroshi
    INTERNAL MEDICINE, 2018, 57 (04) : 457 - 468
  • [36] DIFFERENTIAL MICRORNA EXPRESSION IN PLASMA MICROVESICLES PREDICT HEPATOCELLULAR CARCINOMA REGULATORY PATHWAYS
    Cheng, R.
    Budzinska, M.
    Tu, T.
    McCaughan, G.
    McLennan, S.
    Shackel, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S576 - S577
  • [37] A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma
    Lan, Tian
    Lu, Yunyan
    Xiao, Zunqiang
    Xu, Haibin
    He, Junling
    Hu, Zujian
    Mao, Weimin
    PEERJ, 2019, 7
  • [38] MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
    Xiang, Zuo-Lin
    Zhao, Xiao-Mei
    Zhang, Li
    Yang, Ping
    Fan, Jia
    Tang, Zhao-You
    Zeng, Zhao-Chong
    ONCOTARGET, 2016, 7 (52) : 87246 - 87256
  • [39] Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma
    Afshari, Afsoon
    Yaghobi, Ramin
    Karimi, Mohammad Hossein
    Mowla, Javad
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [40] Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma
    Afsoon Afshari
    Ramin Yaghobi
    Mohammad Hossein Karimi
    Javad Mowla
    BMC Gastroenterology, 21